The Histopathology of Kidney Changes in Rats and Monkeys Following Intravenous Administration of Massive Doses of FCE 26184,Human Basic Fibroblast Growth Factor

Abstract

Intravenous administration of human basic fibroblast growth factor up to 100 μg/kg/day to Sprague-Dawley rats caused changes in the kidneys that included enlargement, vacuolation, and karyomegaly of podocytes in glomeruli, dilatation and cast formation in tubules, thickening of the media in the lobular arteries, and hyperplasia of the epithelium of the papilla and collecting ducts. In cynomolgus monkeys there was hyperplasia of the parietal epithelium of Bowman's capsule in the glomeruli, tubular dilatation, and minimal arteriopathy. These changes were only seen at 100 μg/kg/day. The development and eventual recovery over time were investigated in a sequence of sacrifices. In monkeys the first changes were seen after 7 days of treatment, but in rats only after 16 days. In both species the changes had partially resolved after 30 days of recovery and were considered to return to normal after 60 days without treatment. The morphological changes were accompanied by functional alterations that included proteinuria and raised blood urea. Changes that occurred in other tissues including bone, red blood cells, adrenals, ovaries, liver, gall bladder, spleen, mesenteric lymph nodes, thymus, aorta, salivary glands, and injection site are not described in this paper.

Keywords

Glomerulus proteinuria tubules collecting ducts arteriopathy time of onset recovery electron microscopy

References

Baird A. , Esch F. , Mormede P. , Ueno N. , Ling N. , Bohlen P. , Ying SY , Wehrenberg WB , and Guillemin R. (1986). Molecular characterization of fibroblast growth factor: Distribution and biological activities in various tissues. Recent Prog. Horm. Res. 42: 143-205.

Baird A. , Ueno N. , Esch F. , and Ling N. (1987). Distribution of fibroblast growth factors (FGFs) in tissues and structure-function studies with synthetic fragments of basic TFG. J. Cell Physiol. 5(suppl.) : 101-105.

Bertani T. , Poggi A. , Rozzoni R. , Delaini F. , Sacchi G. , Thoua Y. , Mecca G. , Remuzzi G. , and Donati MB (1982). Adriamycin-induced nephrotic syndrome in rats . Lab. Invest. 46: 16-23.

Fine LG , Ong ACM , and Norman JT (1993). Mechanism of tubulo-interstitial injury in progressive renal diseases. Eur. J. Clin. Invest. 23: 259-265.

Hondermarck H. , Courty J. , Boilly B. , and Thomas D. (1990). Distribution of intravenously administered acidic and basic fibroblast growth factors in the mouse. Experientia 46: 973-974.

Issandou M. and Darbon J. -M (1991). Basic fibroblast growth factor stimulates glomerular mesangial cell proliferation through a protein kinase C-independent pathway . Growth Factors 5: 255-264.

Remuzzi G. and Bertani T. (1990). Is glomerulosclerosis a consequence of altered glomerular permeability to macro molecules? Kidney Int. 38: 384-394.

Segal R. and Fine LG (1989). Polypeptide growth factors and the kidney. Kidney Int. 36(suppl.27): S2-S10.

Takeuchi A. , Yoshizawa N. , Yamamoto M. , Sawasaki Y. , Oda T. , Senoo A. , Niwa H. , and Fuse Y. (1992). Basic fibroblast growth factor promotes proliferation of rat glomerular visceral epithelial cells in vitro. Am. J. Pathol. 141(1): 107-116.

10.

Zhang G. , Ichimura T. , Wallin A. , Kan M. , and Stevens JL (1991). Regulation of rat proximal tubule epithelial cell growth by fibroblast growth factors, insulin-like growth factor-1 and transforming growth factor-β, and analysis of fibroblast growth factors in rat kidney . J. Cell. Physiol. 148: 295-305.